Mitochondrial membrane permeabilization in cell death

被引:3189
作者
Kroemer, Guido
Galluzzi, Lorenzo
Brenner, Catherine
机构
[1] Univ Paris 11, Unit Apoptosis Canc & Immun, INSERM, Inst Gustave Roussy, F-94085 Villejuif, France
[2] Univ Versailles St Quentin Yvelines, CNRS, UMR 8159, Versailles, France
关键词
D O I
10.1152/physrev.00013.2006
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
Irrespective of the morphological features of end-stage cell death (that may be apoptotic, necrotic, autophagic, or mitotic), mitochondrial membrane permeabilization (MMP) is frequently the decisive event that delimits the frontier between survival and death. Thus mitochondrial membranes constitute the battleground on which opposing signals combat to seal the cell's fate. Local players that determine the propensity to MMP include the pro- and antiapoptotic members of the Bcl-2 family, proteins from the mitochondrial permeability transition pore complex, as well as a plethora of interacting partners including mitochondrial lipids. Intermediate metabolites, redox processes, sphingolipids, ion gradients, transcription factors, as well as kinases and phosphatases link lethal and vital signals emanating from distinct subcellular compartments to mitochondria. Thus mitochondria integrate a variety of proapoptotic signals. Once MMP has been induced, it causes the release of catabolic hydrolases and activators of such enzymes (including those of caspases) from mitochondria. These catabolic enzymes as well as the cessation of the bioenergetic and redox functions of mitochondria finally lead to cell death, meaning that mitochondria coordinate the late stage of cellular demise. Pathological cell death induced by ischemia/reperfusion, intoxication with xenobiotics, neurodegenerative diseases, or viral infection also relies on MMP as a critical event. The inhibition of MMP constitutes an important strategy for the pharmaceutical prevention of unwarranted cell death. Conversely, induction of MMP in tumor cells constitutes the goal of anticancer chemotherapy.
引用
收藏
页码:99 / 163
页数:65
相关论文
共 904 条
[1]
Expanding insights of mitochondrial dysfunction in Parkinson's disease [J].
Abou-Sleiman, PM ;
Muqit, MMK ;
Wood, NW .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (03) :207-219
[2]
The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides [J].
Abramov, AY ;
Duchen, MR .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2005, 360 (1464) :2309-2314
[3]
Bax interacts with the voltage-dependent anion channel and mediates ethanolinduced apoptosis in rat hepatocytes [J].
Adachi, M ;
Higuchi, H ;
Miura, S ;
Azuma, T ;
Inokuchi, S ;
Saito, H ;
Kato, S ;
Ishii, H .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 287 (03) :G695-G705
[4]
Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury [J].
Adlam, VJ ;
Harrison, JC ;
Porteous, CM ;
James, AM ;
Smith, RAJ ;
Murphy, MP ;
Sammut, IA .
FASEB JOURNAL, 2005, 19 (09) :1088-1095
[5]
Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2 [J].
Adrain, C ;
Creagh, EM ;
Martin, SJ .
EMBO JOURNAL, 2001, 20 (23) :6627-6636
[6]
Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
[7]
Antiapoptotic Effect of nicorandil mediated by mitochondrial ATP-sensitive potassium channels in cultured cardiac myocytes [J].
Akao, M ;
Teshima, Y ;
Marbán, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (04) :803-810
[8]
An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic Bcl-2 in human dopaminergic SH-SY5Y cells [J].
Akao, Y ;
Maruyama, W ;
Yi, H ;
Shamoto-Nagai, M ;
Youdim, MBH ;
Naoi, M .
NEUROSCIENCE LETTERS, 2002, 326 (02) :105-108
[9]
PROTECTIVE EFFECTS OF DILTIAZEM AND RYANODINE AGAINST ISCHEMIA-REPERFUSION INJURY IN NEONATAL RABBIT HEARTS [J].
AKITA, T ;
ABE, T ;
KATO, S ;
KODAMA, I ;
TOYAMA, J .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 106 (01) :55-66
[10]
ALIROL E, IN PRESS ONCOGENE